/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n\n \n \n \n\n \n \n \n
\n\n \n
\n  Recent News: Oncothyreon Inc
\n \n \n\n\n \n\n \n\n \n \n \n\n \n\n \n\n \n \n \n\n \n\n \n\n \n \n \n\n \n\n \n\n \n \n \n\n \n\n \n\n \n \n \n\n
02/02/10 
8:02 AM EST 
\n \n \n Oncothyreon to present at BIO CEO & Investor Conference - PR Newswire\n \n
12/10/09 
8:03 AM EST 
\n \n \n Oncothyreon announces initiation of Phase 3 trial of Stimuvax in Asian patients with NSCLC - CNW\n \n
12/10/09 
8:01 AM EST 
\n \n \n Oncothyreon announces initiation of Phase 3 trial of Stimuvax in Asian patients with NSCLC - PR Newswire\n \n
11/16/09 
8:18 AM EST 
\n \n \n Oncothyreon's PX-866 PI-3 kinase inhibitor named among Top 10 most promising oncology products for partnering by Windhover - CNW\n \n
11/16/09 
8:15 AM EST 
\n \n \n Oncothyreon's PX-866 PI-3 kinase inhibitor named among Top 10 most promising oncology products for partnering by Windhover - PR Newswire\n \n
\n
\n \n\n\n\n\n\n
Feb 09 5:50 PM EST
\n\n\n\n \n
\n\n");